NCT04358770View on ClinicalTrials.gov

Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream

PHASE1CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

March 2, 2018

Primary Completion Date

April 27, 2018

Study Completion Date

May 11, 2018

Conditions
Bioequivalence Study
Interventions
DRUG

Clocortolone Pivalate

Cream, 0.1%

Trial Locations (1)

75234

WayCro, Dallas

All Listed Sponsors
collaborator

WAYCro

UNKNOWN

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT04358770 - Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream | Biotech Hunter | Biotech Hunter